The Rosen Law Firm, P.A. announces that a class action lawsuit has been filed on behalf of all purchasers of the securities of Molycorp, Inc. (NYSE:MCP) between August 2, 2012 and August 7, 2013.
To join the Molycorp class action, visit the firm’s website at http://www.rosenlegal.com, or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free, at 866-767-3653; you may also email at firstname.lastname@example.org or email@example.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According lawsuit, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company's reported inventory was materially understated; (ii) the Company overstated its income tax benefit in the first quarter of 2013 by approximately $6.5 million; (iii) the Company lacked adequate internal and financial controls; and (iv) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times. The lawsuit claims that when these adverse facts entered the market, the value of Molycorp shares fell, damaging investors.
If you wish to serve as lead plaintiff, you must move the Court no later than October 15, 2013. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm, toll-free, at 866-767-3653, or via e-mail at firstname.lastname@example.org email@example.com. You may also visit the firm’s website at http://www.rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
The Rosen Law Firm P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
275 Madison Avenue 34th Floor
New York, New York 10016
Toll Free: 1-866-767-3653
|ALERT: The Rosen Law Firm Announces Class Action Against Biolase, Inc. -- BIOL (2013/8/28)|
|EQUITY ALERT: The Rosen Law Firm Announces Class Action Against Aegerion Pharmaceuticals, Inc. -- AEGR (2014/1/29)|
|The Rosen Law Firm Announces Class Action Against KiOR, Inc. - KIOR ()|
|ALERT: Rosen Law Firm Announces Class Action Against AmTrust Financial Services, Inc. -- AFSI (2014/2/6)|
|EQUITY ALERT: Rosen Law Firm Announces Class Action Lawsuit Against Teva Pharmaceutical Industries Limited --- TEVA (2014/1/9)|
|ALERT: Rosen Law Firm Announces Class Action Lawsuit Against ECOtality, Inc. -- ECTY ()|
|EQUITY ALERT: Rosen Law Firm Announces Class Action Lawsuit Against OSI Systems, Inc. -- OSIS (2014/1/11)|
|EQUITY ALERT: Rosen Law Firm Announces Class Action Lawsuit Against Insys Therapeutics, Inc. -- INSY (2014/1/11)|
|ALERT: Rosen Law Firm Announces Class Action Lawsuit Against Ixia -- XXIA (2013/11/27)|
|The Rosen Law Firm Announces Class Action Charging Securities Violations Against Immunomedics, Inc. -- IMMU (2014/3/11)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.